title: Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
abstract: Although there is a mounting body of evidence that eosinophils are recruited to sites of allergic inflammation by a number of beta-chemokines, particularly eotaxin and RANTES, the receptor that mediates these actions has not been identified. We have now cloned a G protein-coupled receptor, CC CKR3, from human eosinophils which, when stably expressed in AML14.3D10 cells bound eotaxin, MCP-3 and RANTES with Kds of 0.1, 2.7 and 3.1 nM, respectively. CC CKR3 also bound MCP-1 with lower affinity, but did not bind MIP-1 alpha or MIP-1 beta. Eotaxin, RANTES, and to a lessor extent MCP-3, but not the other chemokines, activated CC CKR3 as determined by their ability to stimulate a Ca(2+) -flux. Competition binding studies on primary eosinophils gave binding affinities for the different chemokines which were indistinguishable from those measured with CC CKR3. Since CC CKR3 is prominently expressed in eosinophils we conclude that CC CKR3 is the eosinophil eotaxin receptor. Eosinophils also express a much lower level of a second chemokine receptor, CC CKR1, which appears to be responsible for the effects of MIP-1 alpha.
authors.affiliation: Department of Inflammation Research, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
authors.forename: B L
authors.initials: BL
authors.lastname: Daugherty
authors.forename: S J
authors.initials: SJ
authors.lastname: Siciliano
authors.forename: J A
authors.initials: JA
authors.lastname: DeMartino
authors.forename: L
authors.initials: L
authors.lastname: Malkowitz
authors.forename: A
authors.initials: A
authors.lastname: Sirotina
authors.forename: M S
authors.initials: MS
authors.lastname: Springer
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D054413:Chemokine CCL11; D018946:Chemokine CCL5 / Q000378:metabolism / Q000494:pharmacology; D054410:Chemokine CCL7; D018925:Chemokines / Q000494:pharmacology; D019742:Chemokines, CC; D002631:Chemotactic Factors, Eosinophil / Q000378:metabolism; D003001:Cloning, Molecular; D016207:Cytokines / Q000378:metabolism / Q000494:pharmacology*; D017931:DNA Primers; D004804:Eosinophils / Q000276:immunology*; D006801:Humans; D007700:Kinetics; D008969:Molecular Sequence Data; D018945:Monocyte Chemoattractant Proteins / Q000378:metabolism / Q000494:pharmacology; D016133:Polymerase Chain Reaction; D054397:Receptors, CCR3; D019707:Receptors, Chemokine; D018121:Receptors, Cytokine / Q000096:biosynthesis / Q000378:metabolism*; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000378:metabolism; D017386:Sequence Homology, Amino Acid; D014162:Transfection; D014407:Tumor Cells, Cultured
chemical_list: C515456:CCL11 protein, human; C515450:CCL7 protein, human; C515350:CCR3 protein, human; D054413:Chemokine CCL11; D018946:Chemokine CCL5; D054410:Chemokine CCL7; D018925:Chemokines; D019742:Chemokines, CC; D002631:Chemotactic Factors, Eosinophil; D016207:Cytokines; D017931:DNA Primers; D018945:Monocyte Chemoattractant Proteins; D054397:Receptors, CCR3; D019707:Receptors, Chemokine; D018121:Receptors, Cytokine; D011994:Recombinant Proteins; D002118:Calcium